In a study of Lumachi et al. (14), they found the sensitivity of CEA and CA 15-3 as 38.1% and 61.1% and the specificity of both tumor markers as 98.8% and 91.2%, respectively, in detecting breast cancer recurrence. This evidence concerns the gene CEACAM5 and breast carcinoma.